PAX2 and urogenital neoplasm: To the best of our knowledge, this is the first review that includes patients who have been identified with PAX2 mutations associated exclusively renal abnormalities such as CAKUTs, renal interstitial fibrosis, renal hypoplasia, cystic disorders, nephrotic syndrome and urogenital cancers.